VEGFA and Alzheimer disease: To examine whether the hippocampal sulfated GAG functionalities are altered in AD, we tested their capacities to potentiate the mitogenic activities of FGF-2 and VEGF, as well as the neuritogenic activity of BDNF, in cultured cells.